Finance

Lists
Why is MRVL down 4,17%?
Dive Deeper
MRVL:CVE
Marvel Biosciences Corp
0,12 CA$
-4,17%
(-0,0050) 1D
3 նոյ, 16:00:00 GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for MRVL...
Open
0,12 CA$
High
0,12 CA$
Low
0,12 CA$
Mkt. cap
8,49 մլն
Avg. vol.
80,66 հզր
Volume
31,67 հզր
52-wk high
0,25 CA$
52-wk low
0,10 CA$
EPS
-0,03 CA$
Beta
0,21
Shares outstanding
63,03 մլն
Open
0,12 CA$
High
0,12 CA$
Low
0,12 CA$
Mkt. cap
8,49 մլն
Avg. vol.
80,66 հզր
Volume
31,67 հզր
52-wk high
0,25 CA$
52-wk low
0,10 CA$
EPS
-0,03 CA$
Beta
0,21
Shares outstanding
63,03 մլն
News stories
From web sources and news partners
About Marvel Biosciences Corp
CEO-
Employees-
Founded2021
HeadquartersՔելգերի, Ալբերտա, Կանադա
Sector-
Industry-
Websitemarvelbiotechnology.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025 թ. հլս
2025 թ. հոկ
2026 թ. հնվ
2026 թ. ապր
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
250,56 հզր
57,46 հզր
5,26 հզր
72,14 հզր
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
220,93 հզր
189,29 հզր
245,38 հզր
262,03 հզր
Operating expense
488,69 հզր
252,83 հզր
256,72 հզր
340,06 հզր
Total operating expenses
488,69 հզր
252,83 հզր
256,72 հզր
340,06 հզր
Operating income
-488,69 հզր
-252,83 հզր
-256,72 հզր
-340,06 հզր
Other non operating income
-531,64 հզր
-10,52 հզր
-14,17 հզր
458,25 հզր
EBT including unusual items
-1,19 մլն
-342,26 հզր
-295,58 հզր
436,71 հզր
EBT excluding unusual items
-1,19 մլն
-342,26 հզր
-295,58 հզր
80,92 հզր
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,19 մլն
-342,26 հզր
-295,58 հզր
436,71 հզր
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
72,00
-
-
-
Interest expense
-161,77 հզր
-56,40 հզր
-56,35 հզր
-40,27 հզր
Net interest expenses
-161,70 հզր
-56,40 հզր
-56,35 հզր
-40,27 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps